NOVA LEAP HEALTH CORP(TSX-V:NLH) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to NLH. NLH was compared to 17 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for NLH as it has an excellent financial health rating, but there are worries on the profitability. NLH is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

NLH had negative earnings in the past year.

NLH had a positive operating cash flow in the past year.

In multiple years NLH reported negative net income over the last 5 years.

Each year in the past 5 years NLH had a positive operating cash flow.

1.2 Ratios

The Return On Assets of NLH (-2.20%) is comparable to the rest of the industry.

NLH has a Return On Equity of -2.51%. This is comparable to the rest of the industry: NLH outperforms 56.25% of its industry peers.

The Return On Invested Capital of NLH (3.61%) is better than 75.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.2%
ROE	-2.51%
ROIC	3.61%

ROA(3y)-0.65%

ROA(5y)-0.46%

ROE(3y)-0.25%

ROE(5y)-0.58%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 3.73%, NLH is in line with its industry, outperforming 56.25% of the companies in the same industry.

Looking at the Gross Margin, with a value of 38.56%, NLH is in line with its industry, outperforming 56.25% of the companies in the same industry.

In the last couple of years the Gross Margin of NLH has grown nicely.

		Industry Rank	Sector Rank
OM	3.73%
PM (TTM)	N/A
GM	38.56%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.23%

GM growth 5Y3.09%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.

NLH has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, NLH has more shares outstanding

NLH has a better debt/assets ratio than last year.

2.2 Solvency

NLH has an Altman-Z score of 4.96. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of NLH (4.96) is better than 81.25% of its industry peers.

The Debt to FCF ratio of NLH is 0.74, which is an excellent value as it means it would take NLH, only 0.74 years of fcf income to pay off all of its debts.

NLH's Debt to FCF ratio of 0.74 is amongst the best of the industry. NLH outperforms 100.00% of its industry peers.

A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.

NLH's Debt to Equity ratio of 0.04 is amongst the best of the industry. NLH outperforms 100.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	0.74
Altman-Z	4.96

ROIC/WACC0.5

WACC7.29%

2.3 Liquidity

A Current Ratio of 1.76 indicates that NLH should not have too much problems paying its short term obligations.

NLH has a better Current ratio (1.76) than 93.75% of its industry peers.

NLH has a Quick Ratio of 1.76. This is a normal value and indicates that NLH is financially healthy and should not expect problems in meeting its short term obligations.

With an excellent Quick ratio value of 1.76, NLH belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.76
Quick Ratio	1.76

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NLH have decreased strongly by -12.50% in the last year.

NLH shows a decrease in Revenue. In the last year, the revenue decreased by -2.58%.

The Revenue has been growing by 20.37% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-12.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-155.28%

Revenue 1Y (TTM)-2.58%

Revenue growth 3Y14.79%

Revenue growth 5Y20.37%

Sales Q2Q%-2.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y214.44%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-31.18%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NLH. In the last year negative earnings were reported.

NLH is valuated rather expensively with a Price/Forward Earnings ratio of 17.78.

Compared to the rest of the industry, the Price/Forward Earnings ratio of NLH indicates a rather cheap valuation: NLH is cheaper than 87.50% of the companies listed in the same industry.

NLH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	17.78

4.2 Price Multiples

NLH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NLH is cheaper than 75.00% of the companies in the same industry.

Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	9.97
EV/EBITDA	9.98

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NLH!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NOVA LEAP HEALTH CORP

TSX-V:NLH (2/21/2025, 7:00:00 PM)

0.26

+0.02 (+8.33%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)11-07 2024-11-07

Earnings (Next)03-06 2025-03-06

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners18.79%

Ins Owner ChangeN/A

Market Cap22.70M

Analysts84.44

Price Target0.61 (134.62%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-18.23%

Min Revenue beat(2)-30.71%

Max Revenue beat(2)-5.76%

Revenue beat(4)0

Avg Revenue beat(4)-22.55%

Min Revenue beat(4)-30.71%

Max Revenue beat(4)-5.76%

Revenue beat(8)0

Avg Revenue beat(8)-26.32%

Revenue beat(12)0

Avg Revenue beat(12)-25.35%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-39.36%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	17.78
P/S	0.62
P/FCF	9.97
P/OCF	9.97
P/B	0.87
P/tB	5.04
EV/EBITDA	9.98

EPS(TTM)-0.01

EYN/A

EPS(NY)0.01

Fwd EY5.62%

FCF(TTM)0.03

FCFY10.03%

OCF(TTM)0.03

OCFY10.03%

SpS0.42

BVpS0.3

TBVpS0.05

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.2%
ROE	-2.51%
ROCE	5.02%
ROIC	3.61%
ROICexc	3.89%
ROICexgc	26.97%
OM	3.73%
PM (TTM)	N/A
GM	38.56%
FCFM	6.24%

ROA(3y)-0.65%

ROA(5y)-0.46%

ROE(3y)-0.25%

ROE(5y)-0.58%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.23%

GM growth 5Y3.09%

F-Score7

Asset Turnover1.22

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	0.74
Debt/EBITDA	0.48
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	10.96
Cash Conversion	101.2%
Profit Quality	N/A
Current Ratio	1.76
Quick Ratio	1.76
Altman-Z	4.96

F-Score7

WACC7.29%

ROIC/WACC0.5

Cap/Depr(3y)2.81%

Cap/Depr(5y)2.43%

Cap/Sales(3y)0.12%

Cap/Sales(5y)0.1%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-12.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-155.28%

EPS Next Y214.44%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.58%

Revenue growth 3Y14.79%

Revenue growth 5Y20.37%

Sales Q2Q%-2.25%

Revenue Next Year-31.18%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y636.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-99.95%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-7.18%

FCF growth 3Y-10.89%

FCF growth 5YN/A

OCF growth 1Y-10.42%

OCF growth 3Y-10.57%

OCF growth 5YN/A

NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens